Skip to Content
Merck
All Photos(1)

Documents

M4141

Sigma-Aldrich

Methanesulfonic acid solution

4 M (with 0.2% (w/v) tryptamine)

Synonym(s):

Sulfomethane

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CH3SO3H
CAS Number:
75-75-2
Molecular Weight:
96.11
Beilstein:
1446024
EC Number:
200-898-6
MDL number:
MFCD00007518
UNSPSC Code:
12352209
PubChem Substance ID:
24896907
NACRES:
NA.21

form

liquid

Quality Level

200

concentration

4 M (with 0.2% (w/v) tryptamine)

storage temp.

2-8°C

SMILES string

CS(O)(=O)=O

InChI

1S/CH4O3S/c1-5(2,3)4/h1H3,(H,2,3,4)

InChI key

AFVFQIVMOAPDHO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

For complete protein and peptide hydrolysis with tryptophan recovery. After hydrolysis the samples are diluted prior to amino acid analysis.

Packaging

Ampules sealed under argon.

Caution

air sensitive, store under inert conditions

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H290,H302,H314,H317,H335

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 2

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000360543
0000360543
0000262047
SLCF7271
SLBW6855

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

L-Tryptophan reagent grade, ≥98% (HPLC)

Sigma-Aldrich

T0254

L-Tryptophan

Gulfam Ahmad et al.
Frontiers in pharmacology, 11, 556020-556020 (2020-10-13)
Chronic inflammatory bowel disease (IBD) is a condition with multifactorial pathophysiology. To date, there is no permanent cure and the disease is primarily managed by immunosuppressive drugs; long-term use promotes serious side effects including increased risk malignancies. The current study
Luke F Gamon et al.
Redox biology, 36, 101586-101586 (2020-06-07)
The precise characterization and quantification of oxidative protein damage is a significant challenge due to the low abundance, large variety, and heterogeneity of modifications. Mass spectrometry (MS)-based techniques at the peptide level (proteomics) provide a detailed but limited picture due
Chris Twelves et al.
Breast cancer research and treatment, 148(3), 553-561 (2014-11-09)
Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women
Eric D Nacsa et al.
Organic letters, 15(1), 38-41 (2012-12-15)
The cyclopropenone catalyzed nucleophilic substitution of alcohols by methanesulfonate ion with inversion of configuration is described. This work provides an alternative to the Mitsunobu reaction that avoids the use of azodicarboxylates and generation of hydrazine and phosphine oxide byproducts. This
Norio Murai et al.
Organic letters, 14(11), 2818-2821 (2012-05-18)
A one-pot primary aminomethylation of aryl halides, triflates, mesylates, and tosylates via Suzuki-Miyaura cross-coupling reactions with sodium phthalimidomethyltrifluoroborate followed by deamidation with ethylenediamine is reported.
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service